Parisotto Shannon M sold $600K of CRL
Parisotto Shannon M (CEVP, Disc & Safety Assessment) sold 2,039 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) at $294.12 ($0.60M total) on 2026-08-19 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The transaction is small relative to CRL's float and unlikely to affect market perception.
Market read
Limited relevance; primarily of interest to existing shareholders monitoring insider activity.
What to watch
Potential upcoming regulatory or product developments not disclosed could influence insider behavior.
Background
Form 4 filings disclose insider trades; this filing reports a routine sale by a senior officer.
Ticker impact
Officer Shannon M. Parisotto sold 2,039 shares for $599,710, reducing her stake to 4,807 shares via a 10b5‑1 plan.
No significant price impact expected.
Sale size is modest relative to market cap and follows a pre‑arranged plan.
Market effects
None; insider sale does not affect the broader healthcare services sector.
None; limited to CRL shareholders.
Low; isolated to a single micro‑cap insider transaction.
Counterpoint
The sale could be interpreted as a lack of confidence, but the 10b5‑1 plan suggests it is routine.
Key entities
- CompanyCharles River Laboratories International, Inc.
Provider of laboratory services and products to the pharmaceutical and biotech industries.
- InsiderShannon M. Parisotto
Chief Executive Vice President, Discovery & Safety Assessment.
